Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
March 9, 2026
EUROPE – Revision of the EU General Pharmaceutical Legislation – Regulatory Protections
January 9, 2026
FDA Updates General Wellness and Clinical Decision Support Guidance Documents
December 29, 2025
Medicare and Medicaid Demos Seek to Impose MFN Pricing: An Overview of GENEROUS, GLOBE, and GUARD
June 7, 2026
King & Spalding Secures Significant Summary Judgment Victory for Boehringer Ingelheim in Zantac-Related Litigation